153
Participants
Start Date
April 30, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
February 28, 2014
D/C/F/TAF
DRV 800 mg/COBI 150 mg/FTC 200 mg/TAF 10 mg FDC tablet administered orally once daily
DRV
DRV 800 mg (2 × 400 mg tablets) administered orally once daily
COBI
COBI 150 mg tablet administered orally once daily
FTC/TDF
FTC 200 mg/TDF 300 mg FDC tablet administered orally once daily
D/C/F/TAF Placebo
D/C/F/TAF placebo tablet administered orally once daily
DRV Placebo
DRV placebo tablet administered orally once daily
COBI Placebo
COBI placebo tablet administered orally once daily
FTC/TDF Placebo
FTC/TDF placebo tablet administered orally once daily
Weill Cornell Medical College, New York
North Shore University Hospital / Division of Infectious Diseases, Manhasset
Dupont Circle Physician's Group, Washington D.C.
Whitman-Walker Health, Washington D.C.
Capital Medical Associates, PC, Washington D.C.
CARE-ID, Annandale
Duke University Medical Center, Durham
ID Consultants, P.A., Charlotte
University of South Carolina School of Medicine Division of Infectious Disease, Columbia
Infectious Disease Specialists of Atlanta, Decatur
Mercer University Mercer Medicine, Macon
Orlando Immunology Center, Orlando
IDOCF/ValuhealthMD, LLC, Orlando
Wohlfeiler, Piperato and Associates, LLC, Miami Beach
Gary J. Richmond,M.D.,P.A., Fort Lauderdale
St. Joseph's Comprehensive Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
Be Well Medical Center, Berkley
Henry Ford Health System, Detroit
Hennepin County Medical Center, Minneapolis
Howard Brown Health Center, Chicago
Central West Clinical Research Inc, St Louis
Southwest Infectious Disease Clinical Research Inc, Dallas
DCOL Center for Clinical Research, Longview
Tarrant County Infectious Disease Associates, Fort Worth
Therapeutic Concepts, PA, Houston
Gordon E. Crofoot, MD., PA, Houston
Apex Research, Denver
Denver Infectious Disease Consultants, PLLC, Denver
Kaiser Permanente, Los Angeles
Peter J. Ruane, MD, Inc., Los Angeles
Anthony Mills MD, Inc, Los Angeles
AHF Research Center, Beverly Hills
La Playa Medical Group and Clinical Research, San Diego
Orange Coast Medical Group, Newport Beach
Kasier Permanente Medical Center, San Francisco
TPMG--Clinical Trials Unit, San Francisco
Stanford University, Palo Alto
Alta Bates Summit Medical Center, East Bay AIDS Center, Oakland
Kaiser Permanente Medical Group, Sacramento
Peter Shalit, M.D., Seattle
Brigham and Women's Hospital, Boston
Community Research Initiative (CRI), Boston
Clinical Research Puerto Rico, San Juan
Lead Sponsor
Gilead Sciences
INDUSTRY